Thermo Fisher Scientific Inc.
TMO · NYSE
9/27/2025 | 6/28/2025 | 3/29/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $11,122 | $10,855 | $10,364 | $11,395 |
| % Growth | 2.5% | 4.7% | -9% | – |
| Cost of Goods Sold | $6,470 | $6,807 | $6,119 | $6,928 |
| Gross Profit | $4,652 | $4,048 | $4,245 | $4,467 |
| % Margin | 41.8% | 37.3% | 41% | 39.2% |
| R&D Expenses | $347 | $352 | $342 | $374 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,365 | $1,779 | $2,063 | $1,825 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,712 | $2,131 | $2,405 | $2,199 |
| Operating Income | $1,943 | $1,917 | $1,840 | $2,268 |
| % Margin | 17.5% | 17.7% | 17.8% | 19.9% |
| Other Income/Exp. Net | -$115 | -$206 | -$234 | -$294 |
| Pre-Tax Income | $1,828 | $1,711 | $1,606 | $1,974 |
| Tax Expense | $207 | $92 | $95 | $150 |
| Net Income | $1,616 | $1,617 | $1,507 | $1,830 |
| % Margin | 14.5% | 14.9% | 14.5% | 16.1% |
| EPS | 4.28 | 4.28 | 3.99 | 4.79 |
| % Growth | 0% | 7.3% | -16.7% | – |
| EPS Diluted | 4.27 | 4.28 | 3.98 | 4.78 |
| Weighted Avg Shares Out | 378 | 378 | 378 | 383 |
| Weighted Avg Shares Out Dil | 378 | 378 | 379 | 383 |
| Supplemental Information | – | – | – | – |
| Interest Income | $234 | $297 | $203 | $227 |
| Interest Expense | $347 | $404 | $303 | $384 |
| Depreciation & Amortization | $663 | $685 | $705 | $742 |
| EBITDA | $2,838 | $2,798 | $2,628 | $3,068 |
| % Margin | 25.5% | 25.8% | 25.4% | 26.9% |